US Stock MarketDetailed Quotes

RAPT RAPT Therapeutics

Watchlist
  • 2.450
  • +0.180+7.93%
Close Nov 5 16:00 ET
  • 2.450
  • 0.0000.00%
Post 16:20 ET
85.51MMarket Cap-782P/E (TTM)

RAPT Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
-59.95%1.53M
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
-59.95%1.53M
--0
--0
Cost of revenue
Gross profit
Operating expense
3.41%29.33M
3.03%32.52M
45.51%127.06M
35.96%33.22M
56.47%33.92M
43.29%28.36M
47.36%31.56M
19.58%87.32M
30.02%24.43M
11.17%21.68M
Selling and administrative expenses
-0.48%6.69M
29.21%7.74M
28.75%26.06M
29.66%6.45M
35.79%6.9M
23.66%6.72M
26.12%5.99M
26.21%20.24M
10.82%4.98M
34.58%5.08M
-General and administrative expense
-0.48%6.69M
29.21%7.74M
28.75%26.06M
29.66%6.45M
35.79%6.9M
23.66%6.72M
26.12%5.99M
26.21%20.24M
10.82%4.98M
34.58%5.08M
Research and development costs
4.61%22.64M
-3.10%24.78M
50.56%101M
37.58%26.76M
62.79%27.02M
50.72%21.64M
53.41%25.57M
17.72%67.08M
36.05%19.45M
5.56%16.6M
Operating profit
-3.41%-29.33M
-3.03%-32.52M
-48.10%-127.06M
-35.96%-33.22M
-56.47%-33.92M
-50.00%-28.36M
-51.91%-31.56M
-23.97%-85.8M
-35.47%-24.43M
-16.97%-21.68M
Net non-operating interest income expense
Other net income (expense)
-45.95%1.67M
-12.83%2M
424.48%10.26M
58.18%2.34M
475.17%2.55M
1,221.45%3.08M
641.42%2.29M
39,040.00%1.96M
1,309.52%1.48M
475.42%443K
Other non- operating income (expenses)
-45.95%1.67M
-12.83%2M
424.48%10.26M
58.18%2.34M
475.17%2.55M
1,221.45%3.08M
641.42%2.29M
39,040.00%1.96M
1,309.52%1.48M
475.42%443K
Income before tax
-9.43%-27.66M
-4.27%-30.52M
-39.31%-116.8M
-34.53%-30.88M
-47.73%-31.37M
-31.78%-25.28M
-43.01%-29.27M
-21.15%-83.84M
-28.01%-22.95M
-13.85%-21.24M
Income tax
Net income
-9.43%-27.66M
-4.27%-30.52M
-39.31%-116.8M
-34.53%-30.88M
-47.73%-31.37M
-31.78%-25.28M
-43.01%-29.27M
-21.15%-83.84M
-28.01%-22.95M
-13.85%-21.24M
Net income continuous Operations
-9.43%-27.66M
-4.27%-30.52M
-39.31%-116.8M
-34.53%-30.88M
-47.73%-31.37M
-31.78%-25.28M
-43.01%-29.27M
-21.15%-83.84M
-28.01%-22.95M
-13.85%-21.24M
Minority interest income
Net income attributable to the parent company
-9.43%-27.66M
-4.27%-30.52M
-39.31%-116.8M
-34.53%-30.88M
-47.73%-31.37M
-31.78%-25.28M
-43.01%-29.27M
-21.15%-83.84M
-28.01%-22.95M
-13.85%-21.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-9.43%-27.66M
-4.27%-30.52M
-39.31%-116.8M
-34.53%-30.88M
-47.73%-31.37M
-31.78%-25.28M
-43.01%-29.27M
-21.15%-83.84M
-28.01%-22.95M
-13.85%-21.24M
Basic earnings per share
-7.58%-0.71
-3.95%-0.79
-18.22%-3.05
-26.56%-0.81
-30.16%-0.82
-6.45%-0.66
-10.14%-0.76
-1.98%-2.58
-4.92%-0.64
0.00%-0.63
Diluted earnings per share
-7.58%-0.71
-3.95%-0.79
-18.22%-3.05
-26.56%-0.81
-30.16%-0.82
-6.45%-0.66
-10.14%-0.76
-1.98%-2.58
-4.92%-0.64
0.00%-0.63
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000-59.95%1.53M00
Operating revenue --0--0--0--0--0--0--0-59.95%1.53M--0--0
Cost of revenue
Gross profit
Operating expense 3.41%29.33M3.03%32.52M45.51%127.06M35.96%33.22M56.47%33.92M43.29%28.36M47.36%31.56M19.58%87.32M30.02%24.43M11.17%21.68M
Selling and administrative expenses -0.48%6.69M29.21%7.74M28.75%26.06M29.66%6.45M35.79%6.9M23.66%6.72M26.12%5.99M26.21%20.24M10.82%4.98M34.58%5.08M
-General and administrative expense -0.48%6.69M29.21%7.74M28.75%26.06M29.66%6.45M35.79%6.9M23.66%6.72M26.12%5.99M26.21%20.24M10.82%4.98M34.58%5.08M
Research and development costs 4.61%22.64M-3.10%24.78M50.56%101M37.58%26.76M62.79%27.02M50.72%21.64M53.41%25.57M17.72%67.08M36.05%19.45M5.56%16.6M
Operating profit -3.41%-29.33M-3.03%-32.52M-48.10%-127.06M-35.96%-33.22M-56.47%-33.92M-50.00%-28.36M-51.91%-31.56M-23.97%-85.8M-35.47%-24.43M-16.97%-21.68M
Net non-operating interest income expense
Other net income (expense) -45.95%1.67M-12.83%2M424.48%10.26M58.18%2.34M475.17%2.55M1,221.45%3.08M641.42%2.29M39,040.00%1.96M1,309.52%1.48M475.42%443K
Other non- operating income (expenses) -45.95%1.67M-12.83%2M424.48%10.26M58.18%2.34M475.17%2.55M1,221.45%3.08M641.42%2.29M39,040.00%1.96M1,309.52%1.48M475.42%443K
Income before tax -9.43%-27.66M-4.27%-30.52M-39.31%-116.8M-34.53%-30.88M-47.73%-31.37M-31.78%-25.28M-43.01%-29.27M-21.15%-83.84M-28.01%-22.95M-13.85%-21.24M
Income tax
Net income -9.43%-27.66M-4.27%-30.52M-39.31%-116.8M-34.53%-30.88M-47.73%-31.37M-31.78%-25.28M-43.01%-29.27M-21.15%-83.84M-28.01%-22.95M-13.85%-21.24M
Net income continuous Operations -9.43%-27.66M-4.27%-30.52M-39.31%-116.8M-34.53%-30.88M-47.73%-31.37M-31.78%-25.28M-43.01%-29.27M-21.15%-83.84M-28.01%-22.95M-13.85%-21.24M
Minority interest income
Net income attributable to the parent company -9.43%-27.66M-4.27%-30.52M-39.31%-116.8M-34.53%-30.88M-47.73%-31.37M-31.78%-25.28M-43.01%-29.27M-21.15%-83.84M-28.01%-22.95M-13.85%-21.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -9.43%-27.66M-4.27%-30.52M-39.31%-116.8M-34.53%-30.88M-47.73%-31.37M-31.78%-25.28M-43.01%-29.27M-21.15%-83.84M-28.01%-22.95M-13.85%-21.24M
Basic earnings per share -7.58%-0.71-3.95%-0.79-18.22%-3.05-26.56%-0.81-30.16%-0.82-6.45%-0.66-10.14%-0.76-1.98%-2.58-4.92%-0.640.00%-0.63
Diluted earnings per share -7.58%-0.71-3.95%-0.79-18.22%-3.05-26.56%-0.81-30.16%-0.82-6.45%-0.66-10.14%-0.76-1.98%-2.58-4.92%-0.640.00%-0.63
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data